Trial Condition(s):

Atrial Fibrillation

A digital non-interventional atrial fibrillation (AF) screening study with commercial pulse detection systems (BAYathlon)

Bayer Identifier:

18796

ClinicalTrials.gov Identifier:

NCT02875106

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The primary objective in this study is to identify commercial pulse detection systems (CPDS) parallel to electrocardiogram (ECG) recording within routine clinical setting, which are able to detect atrial fibrillation or sinus rhythm of screened patients.

Inclusion Criteria
- Adult female and male patients for whom the decision to record an ECG was made as per investigator’s routine treatment practice
- Patient able and willing to provide signed informed consent
Exclusion Criteria
- Patients with any comorbidities or abnormalities of heart function or rhythm, which might, in the opinion of the investigator, interfere with the evaluation of study data
- Patients participating in an investigational program with interventions outside of routine clinical practice

Trial Summary

Enrollment Goal
165
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Many Locations, Germany

Status
Recruiting
 

Trial Design